In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

Ehab Atallah; Hagop Kantarjian; Jorge Cortes

doi:10.1038/nm0107-14

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

Ehab Atallah, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	14
Number of pages	1
Journal	Nature Medicine
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/nm0107-14
State	Published - Jan 2007
Externally published	Yes

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nm0107-14

Cite this

@article{c8d05a0c55374a13b47fd4b99eb0d79d,

title = "In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]",

author = "Ehab Atallah and Hagop Kantarjian and Jorge Cortes",

year = "2007",

month = jan,

doi = "10.1038/nm0107-14",

language = "English (US)",

volume = "13",

pages = "14",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

AU - Atallah, Ehab

AU - Kantarjian, Hagop

AU - Cortes, Jorge

PY - 2007/1

Y1 - 2007/1

UR - http://www.scopus.com/inward/record.url?scp=33846086176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846086176&partnerID=8YFLogxK

U2 - 10.1038/nm0107-14

DO - 10.1038/nm0107-14

M3 - Letter

C2 - 17206119

AN - SCOPUS:33846086176

SN - 1078-8956

VL - 13

SP - 14

JO - Nature Medicine

JF - Nature Medicine

IS - 1

ER -

In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [3]

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this